INSMED INC Finance Lease, Right-of-Use Asset, after Accumulated Amortization
INSMED INC (INSM) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $14.21 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $14.21M.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $14.88M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $15.56M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $16.24M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $14.21M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $14.88M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $15.56M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $16.24M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $16.92M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $17.59M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $18.27M 10-K · filed 2026-02-19 |
| 2024-09-30 | $18.95M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $19.63M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $20.31M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $20.98M 10-K · filed 2025-02-20 |
| 2023-09-30 | $21.66M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $22.34M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $23.02M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $23.70M 10-K · filed 2024-02-22 |
| 2022-09-30 | $16.70M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $17.18M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $17.81M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $9.26M 10-K · filed 2023-02-23 |
| 2021-09-30 | $9.53M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $9.79M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $10.06M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.33M 10-K · filed 2022-02-17 |
| 2020-09-30 | $10.60M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $14.54M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.90M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $15.26M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |